CASI Pharma (CASI) Reports Q2 Loss of $0.52

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.52). Revenue for the quarter came in at $3.98 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Swarmer, Inc (SWMR) Reports Q2 Loss of $0.45
• KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance